ArticlePloS one2025
Inaccurate labelling practices in probiotic products: A regulatory shortfall in Accra, Ghana.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Probiotics and the Human Microbiome: Classical Functions, Emerging Systemic Roles, and Future Therapeutic Frontiers.Biology · 2026Review
- Probiotics as Microbiome Modulators in Male Infertility: Rethinking Dysbiosis Across the Gut-Testis Axis.Journal of personalized medicine · 2026Review
- Functional fermented dairy products: a review of mechanisms, health potential, and technological challenges.Frontiers in nutrition · 2026Review
- Factors affecting the viability of probiotics in various food products: a review of current knowledge.Frontiers in microbiology · 2026Review
- Assessment of Antibiotic Resistance and Microbial Contamination in Commercial Veterinary Probiotic Products.Biology · 2025Article
- Probiotic Potential of Traditional and Emerging Microbial Strains in Functional Foods: From Characterization to Applications and Health Benefits.Microorganisms · 2025Review
- Probiotics and Postbiotics for Green Control of Foodborne Pathogens: Intelligent Detection and Biopreservation Strategies for Safer Foods.Foods (Basel, Switzerland) · 2025Review
- Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global market for probiotics has witnessed significant growth in recent years, driven by increased interest in their health benefits. However, amidst the substantial expansion of this industry, there are still challenges regarding their quality control, especially in the aspect of labelling accuracy, hence reliability. This study evaluated the labelling accuracy and availability of probiotic products in Ayawaso West Municipality, Accra, Ghana. Using a stratified sampling design, 120 pharmacies within the Municipality were randomly selected and assessed for availability of probiotics and labels scrutinized. Visual inspection of the product labels was carried out utilizing a probiotic product label assessment checklist developed as a guide. The checklist covered information including brand details, probiotic species/strains, cell quantity, ingredients, label claims, dosage instructions and expiration dates. The checklist was based on recommended labelling requirements by the Joint Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO) and the Council for Responsible Nutrition (CRN) and International Probiotics Association (IPA). The findings from this study revealed 78.3% of pharmacies in the Ayawaso West Municipality offered probiotic supplements and/or probiotic foods. Disparities in recommended label requirements and the labels of probiotic products found within the Municipality was observed. Labelling issues were more prevalent in probiotic foods than supplements. Compliance for the probiotic supplements was 74% and 44% for the probiotic food. Common issues included lack of essential information like cell quantity or CFU (colony-forming-unit), lack of statement of specific probiotic strain contained in the product, lack of scientific references supporting health claims and un-existing bacteria names. The probiotic foods occasionally stated the genus, and some did not indicate species or strain contained in the product. The study sheds light on the gaps in labelling practices in the probiotic market in Ghana and advocates for greater compliance and proper regulation of probiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.